Sodium oxybate or gamma-hydroxybutyrate (GHB) is sold under the brand name Xyrem is a restricted prescription drug licensed for the prevention of cataplexy (sudden, brief episodes of loss of muscle strength) and narcolepsy.
Prescription sodium oxybate and Xyrem have significant differences from the illegal street drug also known as GHB.
Side effects[edit | edit source]
Learn more[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- "Sodium oxybate Uses, Side Effects & Warnings". Drugs.com. Retrieved September 25, 2020.
- "Sodium Oxybate: MedlinePlus Drug Information". medlineplus.gov. Retrieved September 25, 2020.
- Carter, Lawrence P.; Pardi, Daniel; Gorsline, Jane; Griffiths, Roland R. (September 1, 2009). "Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem®): differences in characteristics and misuse". Drug and alcohol dependence. 104 (1–2): 1–10. doi:10.1016/j.drugalcdep.2009.04.012. ISSN 0376-8716. PMC 2713368. PMID 19493637.
adverse reaction Any unintended or unwanted response to a treatment, whether in a clinical trial or licensed treatment. May be minor or serious.